Long-acting GnRH analogues efiect~vely and safely suppress pituitary-gonadal functlon in children with CPP However, the eflects ol long term therapy w~th GnRH-a on the bone mlneral dens~ty of these children has not been studled Uslng dual energy X-ray absorptiometly (Hologic ODR-1000). we evaluated the spinal (Lt-L4) BMD of 9 girls wlth CPP who were previously treated with the GnRH-a, LeuprolldeR compared to control glrls matched lor bone age, body mass Index (BMI), and Tanner stage. Pat~ents were lreated with dailv or deoot iniections of leu~rolide acetate for 2.3 + 1 7 vears (mean + SDI At BMD , . . determination, GnRH-a had been'dlscontlnued for 0 ~-2~e a r s and plt~ltary-~o"adal axis recovewdocumented bv resDonses to GnRH stlmulat~on No slqnlf~cant d~nerences In soma1 BMD wkre observed between CPP and controls.
CPP (n=9)
CONTROLS ( The first sign o f puberty in girls can be observed by either cl~nical examination or the LH and FSH response to GnRH. However, serum esuadiol levels can not be detected. The aim of the study was to develop a method for determine the early increase i n estrogens and therefor we focused our work on.melabolites in the urine. 24h urine was collected from healthy girls with breast development o f stage B, or B, . The volume o f urine was measured, albumin added (0.1% final concenuation) in the samples for analysis. Sorbent solid extraction technology was used for exuaction o f the steroids. BondElut extraction carmdges C18 121 1-3027 were used. The estrogen content was determined with bioMtriux Estradiol enzymatic U kit (nr 6.1483). using P-glucuronidase G7771 from sigma for hydrolyzing estrogens from glucuroconjugates. Total urinary estrogens (esuadiol and esuone) varied between 0.01-0.04 pg per 24h for girls i n Tanner stage B, (n=3) and between 0.23-3.45 pg per 24h for girls in Tanner stage B, (n=4).
Determination o f urinary estrogens seems to be a method to determine whether puberty has started or not. T h~s could be used both in diagnos~s and treatment of precocious pubeny. T o determine whether inhibin secretion differs between ~r e~u b e r t a l and late pubertal females, w e measured inhibin and gonadotropins i n venous samples drawn every 10 minutes from 9pm-7am in 9 prepubertal and 20 late pubertal (Tanner stages IV and V) females. Mean luteinizing hormone (LH), follicle stimulating hormone (FSH) and inhibin concentrations were significantly greater in the late pubertal girls when compared with the prepubertal girls (0.61f.5 vs 4.25k.6 IU/L LH, 1.54t.5 vs 3 . e . 3 lU/L FSH, and 161.0t 32.9 v s 375.5 k 41.1 pg/ml inhibin, mean f SEM, P<0.05 in prepubertal vs fully pubesced girls respectively). The mean number of LH. F S H and inhibin peaks did not increase significantly a s the girls progressed throughout puberty (2.41t.6 v s 4.9f.9 L H peaks110 hours , 3.2f.7 vs 5.0i.2 F S H peaks/lOhours, and 1.41.7 vs 3.4f.4 inhibin peaks110 hours). L H and inhibin peak heights were significantly greater in the late pubertal girls when compared to the prepubertal girls (1.14f.8 vs 5.6f.7 IU/L LH, 2 7 3 f 6 6 vs 479t111 pglml inhibin, ~~0 . 0 5 ) ; although no changes were observed i n F S H peak height. These data suggest that inhibin secretion is pulsatile in the human female with increases in mean concentration and peak height as puberty progresses. These data show that mean concentrations of inhibin are lower i n prepubertal and late pubertal females when compared to males at comparable stages of puberty studied previously i n our lab. The Levels of LH, FSH and p r o l a c t i n (PRL) on GnRH (2pg/kg) and TRH (10pg/kg) t e s t during prepubertal period were compared between the MPHD and the IGHD. The chronological age when the t e s t s were performed was a t 9.8t0.Y years o l d i n both groups. I n boys, AFSH l e v e l s were decreased and basal PRL l e v e l s were increased i n the MPHD as compared w i t h those o f the IGHD t0.9i0.4 vs IO.7tl.Y m l U / m l , 24.7t4.2 vs 12.5Y2.5 ng/ol, respectively). I n g i r l s , basal LH and FSH, peak FSH and AFSH were decreased and basal PRL levels were increased i n the MPHD as compared w i t h those o f the lGHD (3.6t0.9 vs I.0M.4 olU/ml, 2.0t0.0 vs 3 . 8 3 . 3 m I U / m l , 5.2i2.5 vs 19.5Y2.8 mlU/ml, 3.2t6.1 va 15.722.5 mlU/ml, 19.0t3.0 vs 3.5t1.4 ng/mL, respectively). These r e s u l t s suggest t h a t the subnormal response of gonadotropins t o GnRH and the increased l e v e l o f basal PRL might be an available index f o r the prediction o f the absence of puberty i n short c h i l d r e n n t adolescent age. 
INSULIN RESISTANCE (IR) O? PUBERTY I S MEDIATED BY UROWTH HORMONE (OH) AND NOT BY SEX STEROIDS ( S S
)
Many f a c t o r s have been invoked f o r t h e cause o f p u b e r t a l I R , i n c l u d i n g OH, SS, and increasing a d i p o s i t y .
To determine the respective r o l e s of GH and SS i n mediating I R , we studied 24 boys w i t h delayed puberty before and a f t e r random assignment t o one of 4 research groups: Control ( C t r l ) , Testosterone (T) Rx, OH Rx, GH + T Rx. We quantitated t h e i n s u l i n s e n s i t i v i t y index ( I S ) v i a t h e minimal model approach. GH was measured Q 20 m i " f r o m ZOO0 through 0600 v i a t h e Hybritech assay. 41,80 1108.5 31.26 3.97 Body mass index d i d n o t change w i t h GH, but increased s i g n i f i c a n t l y w i t h T, and T t OH. Paired ANOVA, and analysis o f covariance o f the data i n d i c a t e t h a t I R i s h i g h l y c o r r e l a t e d w i t h 08, but not w i t h T. OH i s stimulated hy T. W e conclude t h a t OH i n t h e predominant f a c t o r responsible f o r t h e I R o f puberty.(?unded by Genentech, Inc., and N I H CRC Orant XRR-69). Androgenic steroids p a r t i c i p a t e i n the acceleration of l i n e a r growth and increase i n muscle mass during t h e transformation from t h e prepubertal t o the pubertal man. To determine t h e acute changes i n whole body p r o t e i n and calcium (Ca) metabolism i n t h e prepubert a l human, we studied 6 healthy prepubertal boys (mean age:13+1 y s ) i n the post absorptive s t a t e using a primed 4 hour infusion of 1-13Clleucine and the r e c i~r o c a l ~o o l model. Concomitantlv. bone tion.'Mean I T ] rose from 1 1 5 hg/dL t o 8432125 and weight from 36.826.0 kg t o 39.126.2 a f t e r T therapy. The r a t e of appearance of leucine (an i n d i c a t o r o f proteolysis) was 1.662.24 pMol/kg.min and increased t o 1.985.29 a f t e r T therapy, p=.08. Leucine oxidation decreased from 0.252.04 oMol/kg.min t o 0.13+.02, p=.017; thus the non o x i d a t i v e leucine disappearance. which estimates p r o t e i n synthesis. a l s o increased s i g n i f i c a n t l y from 1.41+.21 pMol/kg.min t o 1.85+.27, p=.033. K i n e t i c studies on 2 subjects showed t h a t a l l i n d i c a t o r s o f bone turnover ( V t ) , accretion (Vo+) and resorption (Vo-) showed an increase by approximately 30% a f t e r T therapy. These r e s u l t s demonstrate f o r the f i r s t time t h a t short term acute administration o f testosterone increases whole body estimates o f p r o t e i n turnover and anabolism and concomitantly increases Ca and bone turnover i n the prepubertal human.
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